Related Experiment Video
Updated: Mar 11, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Aldosterone and Impaired Nocturnal Blood Pressure Decline in Primary Aldosteronism
Ning-Peng Liang1,2, Ning Li1, Hao Wu1
1Department of Cardiovascular Medicine, The Second Affiliated Hospital, Jiangxi Medical College Nanchang University Jiangxi China.
Background:
The loss of physiological nocturnal blood pressure (BP) decline is a major contributor to cardiovascular risk, yet its endocrine underpinnings in primary aldosteronism (PA) remain underexplored. This study aimed to elucidate the dose-dependent relationship between aldosterone excess and circadian BP rhythm disruption and assess whether targeted aldosterone suppression could ameliorate nocturnal dipping.
Methods:
We prospectively analyzed 24-hour ambulatory BP data from 681 patients with confirmed PA, stratified by plasma aldosterone concentration. A subset of 99 patients with adrenal vein sampling-confirmed unilateral PA received targeted, minimally invasive vascular intervention for aldosterone suppression and were evaluated for changes in BP rhythm on the basis of treatment response.
Results:
In multivariable-adjusted models, both log-transformed plasma aldosterone concentration and aldosterone-to-renin ratio were inversely associated with the proportion of nocturnal systolic BP decline (log plasma aldosterone concentration: β=-0.054 [95% CI, -0.087 to -0.020]; P=0.002; log aldosterone-to-renin ratio: β=-0.016 [95% CI, -0.025 to -0.006]; P=0.001). In patients achieving biochemical remission after selective suppression, nighttime systolic BP decreased significantly (mean reduction=-33 mm Hg; Cohen's d_z=2.113). The prevalence of the dipper pattern increased from 14.5% to 39.1% (P<0.001), while no rhythm improvement was observed in nonresponders. Multivariable regression confirmed biochemical success as an independent predictor of nocturnal dip amelioration (P=0.045), irrespective of adrenal imaging phenotype.
Conclusions:
Aldosterone excess contributes directly to circadian BP rhythm disruption in PA. Selective hormonal suppression can ameliorate physiological BP dipping in responsive patients. These findings highlight the value of rhythm-based end points and support aldosterone-targeted modulation as a strategic goal in PA management. Registration: URL: https://www.chictr.org.cn/; Unique Identifier: ChiCTR2200057297.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hormonal Regulation
Antihypertensive Drugs: Direct Renin Inhibitors
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hypertension and Regulation of Blood Pressure

